The MarketWatch News Department was not involved in the creation of this content. bioAffinity Technologies' noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to ...
In a 2024 Journal of Thoracic Oncology review, Haiquan Chen, MD, PhD, of Fudan University Shanghai Cancer Center in China, and colleagues backed the use of selective lymph node dissection (LND) to ...
Introduction: Hook-wire (HW) localization is the most frequently employed approach for preoperative localization of pulmonary ground-glass nodules (GGNs); however, the relative outcomes of ...
CHICAGO - Women with a certain type of lung nodule visible on lung cancer screening CT exams face a higher risk of lung cancer than men with similar nodules, according to a new study being presented ...
bioAffinity Technologies’ noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to confirmed malignancy and immediate treatment bioAffinity Technologies, Inc.
bioAffinity Technologies’ noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to confirmed malignancy and immediate treatment Ground-glass nodules appear in ...
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released another compelling case study in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback